Patent Dispute Over Low Testosterone Treatment Briefed For Federal Circuit

(March 2, 2017, 8:37 AM EST) -- WASHINGTON, D.C. — An Indiana federal judge erred in deeming two patents covering a “breakthrough” treatment for hypogonadism invalid, the patent owners recently told the Federal Circuit U.S. Court of Appeals...
To view the full article, register now.